Search results for "FIBROSIS"

showing 10 items of 901 documents

Esteatosis hepática en la hepatitis crónica por virus C: estudio de los factores de riesgo y relación con el estadio de fibrosis

2009

Fundamento y objetivo La esteatosis hepatica (EH) es un hallazgo histologico frecuente en la infeccion cronica por el virus de la hepatitis C (VHC) que puede influir en el pronostico de la enfermedad. El objetivo del presente estudio prospectivo es valorar los factores asociados a su presencia y su relacion con el estadio de fibrosis en pacientes con infeccion cronica por VHC. Material y metodo Se incluyo a 84 pacientes consecutivos con ARN-VHC positivo, no tratados previamente y a los que se practico una biopsia hepatica. En todos los pacientes se recogieron en el momento de la biopsia variables demograficas, clinicas, analiticas, virales e histologicas. Se practicaron analisis bivariante …

Gynecologymedicine.medical_specialtyLiver steatosisbusiness.industryLiver fibrosisMedicineGeneral MedicinebusinessMedicina Clínica
researchProduct

Die Entwicklung der Myelofibrose bei der "präfibrotischen"cIMF

2002

Zusammenfassung Wegen des erst kurzlich mit Erscheinen der neuen WHO-Klassifikation der chronischen myeloproliferativen Erkrankungen (CMPE) aufgegebenen Festhaltens an einer Knochenmarksfibrose als wesentliches Merkmal der chronischen idiopathischen Myelofibrose (cIMF) sind Verlaufsuntersuchungen zu der Entwicklung einer Myelofibrose (MF) bei dieser Entitat nur von fibrotischen Stadien mit widerspruchlichen Ergebnissen bekannt. Deshalb wurde eine retrospektive Studie an Verlaufsbiopsien von 38 Patienten mit cIMF ohne initiale Fibrose mit der Frage nach der Haufigkeit, der Geschwindigkeit sowie dem Ausmas der Entwicklung einer MF durchgefuhrt. Unabhangig von einer Chemotherapie fanden wir ei…

Gynecologymedicine.medical_specialtymedicine.anatomical_structurebusiness.industryDisease progressionmedicineBone marrowbusinessMyelofibrosismedicine.diseasePathology and Forensic MedicineDer Pathologe
researchProduct

Studies of malformation syndromes of man XIB: the cerebro-hepato-renal syndrome of zellweger: Comparative pathology

1976

A study of 11 autopsied cases of the cerebro-hepato-renal syndrome of Zellweger (ZS) is reported. All cases had severe, persistent congenital hypotonia, hepatic lobular disarray, renal cortical cysts and pulmonary hypoplasia. Many had cardiovascular malformations, hepatomegaly, cerebral cortical gyral maldevelopment and pancreatic islet hyperplasia. Additional, less frequent findings are delineated. Results of iron content studies of hepatic and renal tissues are related to age of survival and possible development of fibrosis.

Heart Defects CongenitalLiver CirrhosisMalePathologymedicine.medical_specialtySiderosisCirrhosisRenal cortical cystsPancreatic islet hyperplasiaIronKidneyNeurologic ManifestationsPulmonary hypoplasiaMaldevelopmentFibrosisHumansMedicineAbnormalities MultipleRadiology Nuclear Medicine and imagingbusiness.industryInfant NewbornBrainInfantGeneral MedicineKidney Diseases Cysticmedicine.diseaseBile Ducts IntrahepaticNeonatal hypotoniaLiverConnective TissuePediatrics Perinatology and Child HealthFemaleHepatic fibrosisbusinessHepatomegalyEuropean Journal of Pediatrics
researchProduct

2019

Background: Accurate assessment of hepatic fibrosis in patients with chronic HBeAg-negative Hepatitis B is of crucial importance not only to predict the long-term clinical course, but also to evaluate antiviral therapy indication. The aim of this study was to prospectively assess the utility of point shear wave elastography (pSWE) for longitudinal non-invasive fibrosis assessment in a large cohort of untreated patients with chronic HBeAg-negative hepatitis B virus (HBV) infection. Methods: 407 consecutive patients with HBeAg-negative HBV infection who underwent pSWE, transient elastography (TE) as well as laboratory fibrosis markers, including fibrosis index based on four factors (FIB-4), a…

Hepatitis B virusmedicine.medical_specialtyFibroTestbusiness.industryGeneral MedicineHepatitis Bmedicine.diseasemedicine.disease_causeGastroenterologydigestive system diseases03 medical and health sciences0302 clinical medicineFibrosis030220 oncology & carcinogenesisInternal medicinemedicine030211 gastroenterology & hepatologyIn patientTransient elastographyHepatic fibrosisbusinessAcoustic radiation force impulse imagingJournal of Clinical Medicine
researchProduct

Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-α

1998

Background: In chronic hepatitis C the relation of circulating adhesion molecules to disease features before, during and after therapy has not been completely established. Aim: To analyse the basal levels of circulating adhesins and the changes induced by interferon in these patients. Methods: We studied, using ELISA assays, the serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) in 52 patients with chronic hepatitis C on entry, prior to finalizing a 6-month course of interferon-α therapy and at the end of the follow-up. Correlations with clinical, virological and histological features, including inflammation and fibrosis, were…

HepatitisHepatologybiologybusiness.industryCell adhesion moleculeHepacivirusmedicine.medical_treatmentHepatitis C virusGastroenterologymedicine.diseasebiology.organism_classificationmedicine.disease_causeCytokineFibrosisInterferonBlood plasmaImmunologyMedicinePharmacology (medical)businessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Recent Advances in Derivation of Functional Hepatocytes from Placental Stem Cells

2013

Abstract: End-stage liver diseases are one of the leading causes of death in the world. Often orthotopic liver transplantation represents the final therapeutic choice. The limits of this approach are the scarcity of donor livers available, and the many side effects related to the administration of immune suppressants to the patients. Cellular therapy for liver diseases is increasingly being viewed as a promising strategy to provide hepatocytes to replenish the parenchymal cells of the organ. This technique suffers of some important limitations, such as the difficulty in isolating sufficient cell numbers (e.g. when adult or foetal hepatocytes are used for transplantation), the limited viabil…

Hepatocyte differentiationMesenchymal stem cells Wharton’s jelly amniotic fluid amniotic membrane immune modulation umbilical cord hepatocyte differentiation functional assays inflammation fibrosis regenerative medicine tissue repair.Settore BIO/16 - Anatomia UmanaMesenchymal stem cellBiologyPlacenta cord bankingRegenerative medicineCell therapySettore MED/38 - Pediatria Generale E Specialisticamedicine.anatomical_structureDevelopmental NeuroscienceImmunologyCancer researchmedicineBone marrowStem cellDevelopmental BiologyAdult stem cellThe Open Tissue Engineering and Regenerative Medicine Journal
researchProduct

Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators

2022

Background & aims: Activation of Kupffer cells and recruitment of monocytes are key events in fibrogenesis. These cells release soluble mediators which induce the activation of hepatic stellate cells (HSCs), the main fibrogenic cell type within the liver. Mer tyrosine kinase (MerTK) signaling regulates multiple processes in macrophages and has been implicated in the pathogenesis of non-alcoholic steatohepatitis-related fibrosis. In this study, we explored if MerTK activation in macrophages influences the profibrogenic phenotype of HSCs. Methods: Macrophages were derived from THP-1 cells or differentiated from peripheral blood monocytes towards MerTK+/CD206+/CD163+/CD209- macrophages. Th…

HepatologyCM conditioned medium ECM extracellular matrix Gas-6 Gas-6 growth arrest-specific gene 6 HSC(s) hepatic stellate cells KC(s) Kupffer cell(s) M-CSF macrophage colony-stimulating factor M2c-like macrophages MerTK Myeloid-epithelial-reproductive tyrosine kinase NAFLD non-alcoholic fatty liver disease NASH NASH non-alcoholic steatohepatitis PMA phorbol 12-myristate 13-acetate TGFβ1 transforming growth factor-β1 THP-1 TIMP1 tissue inhibitor of metalloproteinase 1 VEGF-A vascular endothelial growth factor-A liver fibrosis siRNA small-interfering RNAGas-6; liver fibrosis; M2c-like macrophages; NASH; THP-1GastroenterologyInternal MedicineImmunology and AllergyJHEP Reports
researchProduct

P1086 : Complex effects of adenosine receptor antagonists in models of liver fibrosis

2015

HepatologyChemistryLiver fibrosisPharmacologyPurinergic signallingAdenosine A3 receptorAdenosine receptorJournal of Hepatology
researchProduct

P0455 : IL-4Ra oegulates liver fibrosis differently during progression and reversal phases by modulating the ratio of M1 vs M2 macrophages

2015

Hepatologybusiness.industryLiver fibrosisImmunologyMedicinebusinessJournal of Hepatology
researchProduct

P0431 : IL-4/IL-13 exacerbate liver fibrosis progression through alternatively activated macrophages

2015

Hepatologybusiness.industryLiver fibrosisInterleukin 13ImmunologyMedicinebusinessInterleukin 4Journal of Hepatology
researchProduct